Skip to Content

'
Andrea Milbourne, M.D.

Present Title & Affiliation

Primary Appointment

Professor, Head of the Section of General Gynecology, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Volunteer Faculty, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas Health Science Center Houston, Herman Hospital, and Lyndon B. Johnson Hospital, Houston, TX

Bio Statement

Dr. Milbourne was recruited to The University of Texas MD Anderson Cancer Center in 2002 to provide gynecologic care to women with cancer. In this capacity, she provides a comprehensive range of gynecologic services including counseling around menopausal symptoms, sexual dysfunction, fertility preservation prior to starting cancer treatment, as well as surgical care for common and rare gynecologic problems.

Dr. Milbourne has spearheaded the creation of multidisciplinary guidelines for the care of the pregnant cancer patient. She facilitates and coordinates obstetric and cancer care and serves as a liaison between oncologists at The University of Texas MD Anderson Cancer Center and perinatologists at The University of Texas Health Science Center. Dr. Milbourne provides a limited number of services to pregnant women in their first trimesters.

She also provides care and treatment for patients with preinvasive disease of the cervix, vagina and vulva. Treatments include excisional treatments usually performed in an office setting as well as laser therapy of preinvasive lesions of the cervix, vulva and vagina.

Under Dr. Milbourne’s leadership, the section of General Gynecology has grown to a total of 3 general gynecologists who, with the help of 2 Nurse Practitioners, provide comprehensive care for women with cancer.

Dr. Milbourne received her education from The University of Hawaii John A. Burns School of Medicine. She followed up with her residency in Obstetrics and Gynecology at Harbor-UCLA Medical Center in Los Angeles, California. She was in private practice for several years in Los Angeles, before returning to a teaching role at Harbor-UCLA Medical Center.

Dr. Milbourne is board-certified in Obstetrics and Gynecology and holds medical licenses in both Texas and California.

Office Address

The University of Texas MD Anderson Cancer Center
Department of Gynecologic Oncology & Reproductive Medicine
1155 Pressler Street
Unit Number: 1362
Houston, TX 77030
Room Number: CPB6.3235
Fax: (713) 792-7586

Education & Training

Degree-Granting Education

1992 John A. Burns School of Medicine, Honolulu, HI, MD, Medicine
1990 University of Hawaii, Honolulu, HI, MS, Biochemistry and Biophysics
1986 University of Hawaii, Honolulu, HI, BA, Biology

Postgraduate Training

2/2010 Certification, CO2 Laser Certification Training, The University of Texas MD Anderson Cancer Center, Houston, TX
6/1992-6/1996 Internship and Residency, Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, CA

Board Certifications

2011 American Board of Obstetrics and Gynecology

Experience/Service

Institutional Committee Activities

Chair, The University of Texas MD Anderson Cancer Center, sponsored by Women Faculty Programs, The Road to Professor, a career workshop for Women Associate Professor, 9/2012-present
Member, The University of Texas M.D. Anderson Cancer Center, Psychosocial, Behavioral and Health Services Research Committee (PBHSRC), 9/2010-present
Member, The University of Texas M.D. Anderson Cancer Center, Patient Care Operations Team (PCOT), 1/2010-present
Member, The University of Texas M.D. Anderson Cancer Center, Laser Safety Committee, 11/2009-present
Member, The University of Texas M.D. Anderson Cancer Center, Hodgkin Lymphoma AYA Team Meeting, 2009-present
Member, The University of Texas M.D. Anderson Cancer Center, Clinical Safety and Effectiveness, 11/2007-4/2008
Member, The University of Texas M.D. Anderson Cancer Center, Clinical Research Committee (CRC), 2006-2010
Member, The University of Texas M.D. Anderson Cancer Center, Program Steering Committee, 2/2005-2010
Member, The University of Texas M.D. Anderson Cancer Center, Faculty Senate, 2003-2005
Member, The University of Texas M.D. Anderson Cancer Center, Medical Practice Subcommittee, 2003-2005

Professional Memberships

American Athletic Medical Association
Member, 2006-present
American Board of Obstetrics and Gynecology
Member, 1999
American College of Obstetrics and Gynecology
Fellow, 1996
Flying Samaritans (Physicians who provide care in Mexico)
Member, 1995-2002

Selected Publications

Peer-Reviewed Original Research Articles
1. Costales AB, Milbourne AM, Rhodes HE, Munsell MF, Wallbillich JJ, Brown J, Frumovitz M, Ramondetta LM, Schmeler KM. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix. Gynecol Oncol 129(3):513-6, 6/2013. e-Pub 3/28/2013. PMID: 23541795.
2. Lu KH, Loose DS, Yates MS, Nogueras-Gonzalez GM, Munsell MF, Chen LM, Lynch H, Cornelison T, Boyd-Rogers S, Rubin M, Daniels MS, Conrad P, Milbourne A, Gershenson DM, Broaddus RR. Prospective, Multi-center Randomized Intermediate Biomarker Study of Oral Contraceptive vs. Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome. Cancer Prev Res (Phila). e-Pub 5/2/2013. PMID: 23639481.
3. Wallbillich JJ, Rhodes HE, Milbourne AM, Munsell MF, Frumovitz M, Brown J, Trimble CL, Schmeler KM. Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence. Gynecol Oncol 127(2):312-5, 11/2012. e-Pub 8/4/2012. PMID: 22867736.
4. Pham B, Rhodes H, Milbourne A, Adler-Storthz K, Follen M, Scheurer ME. Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies. Gend Med 9(1 Suppl):S36-47, 2/2012. PMID: 22340639.
5. Cheng YC, Takagi M, Milbourne A, Champlin RE, Ueno NT. Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients. Oncologist 17(2):233-8, 2012. e-Pub 1/26/2012. PMCID: PMC3286172.
6. Cantor SB, Yamal JM, Guillaud M, Cox DD, Atkinson EN, Benedet JL, Miller D, Ehlen T, Matisic J, van Niekerk D, Bertrand M, Milbourne A, Rhodes H, Malpica A, Staerkel G, Nader-Eftekhari S, Adler-Storthz K, Scheurer ME, Basen-Engquist K, Shinn E, West LA, Vlastos AT, Tao X, Beck JR, Macaulay C, Follen M. Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy. Int J Cancer 128(5):1151-68, 3/1/2011. e-Pub 11/9/2010. PMCID: PMC3015005.
7. Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract 7(1):43-7, 1/2011. PMCID: PMC3014510.
8. Nakayama K, Liu P, Detry M, Schover LR, Milbourne A, Neumann J, Rondon G, Thewes B, Champlin RE, Ueno NT. Receiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over time. Biol Blood Marrow Transplant 15(11):1465-74, 11/2009. PMID: 19822307.
9. Park SY, Follen M, Milbourne A, Rhodes H, Malpica A, MacKinnon N, MacAulay C, Markey MK, Richards-Kortum R. Automated image analysis of digital colposcopy for the detection of cervical neoplasia. J Biomed Opt 13(1):014029, Jan-Feb, 1/2008. PMID: 18315387.
10. Marín NM, Milbourne A, Rhodes H, Ehlen T, Miller D, Benedet L, Richards-Kortum R, Follen M. Diffuse reflectance patterns in cervical spectroscopy. Gynecol Oncol 99(3 Suppl 1):S116-20, 12/2005. e-Pub 9/13/2005. PMID: 16165197.
11. Milbourne A, Park SY, Benedet JL, Miller D, Ehlen T, Rhodes H, Malpica A, Matisic J, Van Niekirk D, Atkinson EN, Hadad N, Mackinnon N, Macaulay C, Richards-Kortum R, Follen M. Results of a pilot study of multispectral digital colposcopy for the in vivo detection of cervical intraepithelial neoplasia. Gynecol Oncol 99(3 Suppl 1):S67-75, 12/2005. e-Pub 10/3/2005. PMID: 16202444.
12. Park SY, Collier T, Aaron J, Markey M, Richards-Kortum R, Sokolov K, Mackinnon N, Macaulay C, Coghlan L, Milbourne A, Follen M. Multispectral digital microscopy for in vivo monitoring of oral neoplasia in the hamster cheek pouch model of carcinogenesis. Opt Express 13(3):749-762, 2/7/2005. PMID: 19494935.
13. Benavides J, Chang S, Park S, Richards-Kortum R, Mackinnon N, Macaulay C, Milbourne A, Malpica A, Follen M. Multispectral digital colposcopy for in vivo detection of cervical cancer. Opt Express 11(10):1223-36, 5/19/2003. PMID: 19465988.
14. Dixon PS, Bodner AJ, Okihiro M, Milbourne A, Diwan A, Nakamura JM. Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii. West J Med 152(3):261-7, 3/1990. PMCID: PMC1002326.

Invited Articles
1. Rimes S, Gano J, Milbourne A. Care of the pregnant patient with cancer. Oncology (Williston Park) 22(8 Suppl Nurse Ed):13-22, 7/2008. PMID: 19856566.
2. Milbourne A, Nakamura S, Nakamura JM. The polymerase chain reaction and its applications. Hawaii Med J 48(4):125-6, 4/1989. PMID: 2737899.

Editorials
1. Milbourne A. Access, access, access: cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer 110(5):941-2, 9/1/2007. PMID: 17628490.
2. Rimes S, Gano J, Hahn K, Ramirez M, Milbourne A. Caring for pregnant patients with breast cancer. Oncol Nurs Forum 33(6):1065-9, 11/2006. PMID: 17152656.
Other Articles
1. Nakayama K, Milbourne A, Schover LR, Champlin RE, Ueno NT. Gonadal Failure after treatment of hematologic malignancies: from recognition to management for health-care providers. Nat Clin Pract Oncol 5(2):78-89, 2/2008. PMID: 18235440.

Abstracts
1. Wallbillich J, Rhodes H, Milbourne A, Munsell M, Frumovitz M, Brown J, Schmeler K. Comparing clinical outcomes and evaluating risk factors for recurrence. Proceedings of the 43rd Annual Meeting of the Society of Gynecologic Oncology 125(Suppl 1):S82 (#197), 3/2012.
2. Costales AB, Milbourne A, Rhodes H, Munsell MF, Wallibich JJ, Brown J, Wallibich JJ, Frumovitz M, Schmeler KM. Residual disease and invasive carcinoma in women undergoing hysterectomy for adenocarcinoma in situ (AIS) of the cervix. Proceedings of the 43rd Annual Meeting of the Society of Gynecologic Oncology 125(Suppl 1):S53 (#125), 3/2012.
3. Schlumbrecht M, Sun C, Huang M, Milbourne A, Bodurka D. Survivorship care: Who do gynecologic cancer patients prefer?. Gynecologic Oncology 125(Suppl 1):S76, 3/2012.
4. Milbourne A, Sun CC, Fanale MA, Theriault RL, Rimes SA, Litton JK, Ramirez MM. Pregnancy outcomes in women with cancer. J Clin Oncol 30(Suppl):6116, 2012.
5. Milbourne A, Sung K-B, Liang C, Descour M, Follen M, Malpica A, Richards-Kortum R. In Vivo microscopic imaging of cervix by fiber optic confocal microscopy. Preventing and Controlling Cervical Cancer in the New Millennium 5(SS8-03):107, 2003.
6. Milbourne A, Benavides JM, Chang S, Mackinnon N, MacAulay C, Follen M, Richards-Kortum R. Multispectral digital colposcopy for the detection of cervical neoplasia. Preventing and Controlling Cervical Cancer in the New Millennium 5 5(SS15-01):117, 2003.
7. Milbourne A, Benedet JL, Chang S, Mackinnon N, MacAulay C, Follen M, Richards-Kortum R. Technology assessment of fluorescence and reflectance spectroscopy. Preventing and Controlling Cervical Cancer in the New Millennium 5:115, 2003.

Book Chapters
1. Milbourne A, Follen M. Preinvasive Disease of the Lower Genital Tract. In: Gynecologic Cancer. Springer, 20-29, 2005.

Manuals, Teaching Aids, Other Teaching Publications
1. Milbourne A. Redefining Cancer Care. OncoLog, 1/2009.
2. Milbourne A. Prevention and treatment of abnormal uterine bleeding during chemotherapy. Up to Date, 10/2006.
3. Milbourne A. Clinical Discussion Diagnostic Guidelines: Abnormal Pap Test. OncoLog, Compass, 3/2003.

Last updated: 3/8/2013